melarsoprol 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 3336 | 494-79-1 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
Arsenical used in trypanosomiases. It may cause fatal encephalopathy and other undesirable side effects.
|
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 60 | mg | P |
ADMET properties:
None
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | P01CD01 | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS ANTIPROTOZOALS AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS Arsenic compounds |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000977 | Antiparasitic Agents |
| MeSH PA | D000981 | Antiprotozoal Agents |
| MeSH PA | D014344 | Trypanocidal Agents |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| African trypanosomiasis | indication | 27031003 | DOID:10112 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 4.55 | Basic |
| pKa2 | 1.28 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| D00832 | KEGG_DRUG |
| C0025217 | UMLSCUI |
| CHEBI:6729 | CHEBI |
| CHEMBL166 | ChEMBL_ID |
| D008549 | MESH_DESCRIPTOR_UI |
| DB12864 | DRUGBANK_ID |
| 10311 | PUBCHEM_CID |
| 457 | INN_ID |
| ZF3786Q2E8 | UNII |
| 002964 | NDDF |
| 17990002 | SNOMEDCT_US |
| 714136007 | SNOMEDCT_US |
Pharmaceutical products:
None